Login to Your Account

Patent headaches bedevil migraine space as Lilly bid chalks phase III triple play

By Randy Osborne
Staff Writer

Friday, May 12, 2017

With the migraine prevention space heating up, Eli Lilly and Co.'s Eric Pearlman told BioWorld Today that "having multiple options available and multiple voices trying to convey [the] message is a good thing for the patients.".

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription